Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities

Program contacts by research area:

Fernando P. Bruno, MD, MPH
Center for Translation Research & Implementation Science (CTRIS)
National Heart, Lung, and Blood Institute (NHLBI)
301.496.0886
fernando.bruno@nih.gov

Robin C. Vanderpool, DrPH
Health Communication and Informatics Research Branch
National Cancer Institute (NCI)
240.276.6558
robin.vanderpool@nih.gov

Peer review contact:
Peer review contact information will appear in the applicant's eRA Commons account approximately 2 weeks after the submission date.

Financial and grants management contacts:

Louis Velasco
National Heart, Lung, and Blood Institute (NHLBI)
301.827.7977
louis.velasco@nih.gov

Crystal Wolfrey
National Cancer Institute (NCI)
240.276.6277
crystal.wolfrey@nih.gov

This opportunity is a Notice of Special Interest for research that generates evidence on the real-world effectiveness of telehealth collaboration among healthcare providers for consultation, second opinions, and other purposes, referred to as provider-to-provider telehealth (PPT). PPT offers remote access to critical health expertise that might not exist locally in some rural communities.

Research is expected to:

• Contribute to the advancement of health equity and access to care in rural communities through implementation research focused on telehealth-guided provider-to-provider communication
• Stimulate evidence-based interventional and observational research to investigate the real-world effectiveness of provider-to-provider telehealth in managing the health of rural populations while observing, gathering, and assessing information on implementation
• In settings where evidence of clinical effectiveness of PPT is robust, develop and test implementation strategies while observing and gathering information on the intervention's impact on relevant outcomes

Detailed lists of specific areas of research and project examples are provided on the program website.

General NIH eligibility includes:

• Higher education institutions
  • Public/state controlled institutions
  • Private institutions
• Nonprofit organizations
  • With 501(c)(3) status
  • Without 501(c)(3) status
  • Native American tribal organizations
  • Faith-based or community-based organizations
  • Regional organizations
• Governments
  • State
  • County
  • City or township
  • Special districts
  • Federally recognized Indian/Native American tribal governments
  • Indian/Native American tribal governments (other than federally recognized)
  • Eligible agencies of the federal government
  • U.S. territory or possession
• Other
  • Independent school districts
  • Public housing authorities
  • Indian housing authorities
  • Small businesses
  • For-profit organizations

Related funding announcements may have additional eligibility requirements.

Funding amounts are based on the related funding announcements.

This is a NOSI that is attached to related NIH announcements:

• NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
• Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Applicants should submit proposals to the related announcement and indicate that it is a response to the NOSI.

Investigators planning to submit an application are strongly encouraged to contact and discuss their proposed research with program staff well in advance of the anticipated submission date to better determine appropriateness and interest.

This NOSI expires on October 10, 2026.